In a journey that has seen it launch, get acquired and then launch on its own once again, Citizen Health is back on its feet with a new round of seed funding and a partnership aimed at developing therapies for rare diseases.
The artificial-intelligence-powered health platform aims to connect drugmakers with consenting study participants, in addition to patient communities and real-world data, from preclinical development to after FDA approval.
The
Respecting intellectual property rights, you can read the full content at this link
